ACHL.NASDAQ | Achilles Therapeutics PLC ADR | USA | Healthcare | Biotechnology | 2024-09-30 | 3.651 | 0.116 | 1.5m | $4.2m | $1.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
ACLX.NASDAQ | Arcellx Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.248 | 4.275 | 675k | $6m | $52.3m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
AFMD.NASDAQ | Affimed NV | USA | Healthcare | Biotechnology | 2024-09-30 | 0.361 | 0.024 | 55k | $60k | $68.2k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
AGIO.NASDAQ | Agios Pharm | USA | Healthcare | Biotechnology | 2024-09-30 | 1.333 | 2.561 | 760k | $21.1m | $25.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 8/10 | 80.0% | | Total | 8/10 | 80.0% | |
---|
| |
ALLO.NASDAQ | Allogene Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.05 | 0.382 | 2.2m | $4.8m | $4.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
ALXO.NASDAQ | Alx Oncology Holdings | USA | Healthcare | Biotechnology | 2024-09-30 | 6.835 | 1.619 | 3.6m | $9.3m | $6.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
APLT.NASDAQ | Applied Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.984 | 0.738 | 1.1m | $58.3k | $975.5k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
ARQT.NASDAQ | Arcutis Biotherapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.348 | 0.924 | 2.7m | $3.4m | $40.4m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
ASND.NASDAQ | Ascendis Pharma AS | USA | Healthcare | Biotechnology | 2024-09-30 | 1.255 | 7.627 | 750k | -$1.2m | $104m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 2/10 | 20.0% | | Total | 2/10 | 20.0% | |
---|
| |
ATRA.NASDAQ | Atara Biotherapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.165 | 0.077 | 124.6k | -$1.5m | $1.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 1/10 | 10.0% | | Total | 1/10 | 10.0% | |
---|
| |
ATXS.NASDAQ | Astria Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 7.088 | 3.34 | 4m | $24.1m | $38.1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
AVTE.NASDAQ | Aerovate Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.436 | 0.959 | 400k | $1.1m | $1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
BDTX.NASDAQ | Black Diamond Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 8.887 | 1.659 | 5m | $8.6m | $11m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
BGNE.NASDAQ | BeiGene Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 0.329 | 3.723 | 350k | $11.3m | $63.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
CBAY.NASDAQ | CBAY.NASDAQ | - | - | - | - | 1.416 | 4.066 | 1.6m | - | - | | |
CMRX.NASDAQ | Chimerix Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.557 | 0.099 | 1.4m | $2.1m | $4.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
CYTK.NASDAQ | Cytokinetics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.271 | 6.006 | 1.5m | -$177k | $72.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
DAWN.NASDAQ | Day One Biopharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.479 | 2.641 | 2.5m | $13.7m | $31.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 7/10 | 70.0% | | Total | 7/10 | 70.0% | |
---|
| |
FATE.NASDAQ | Fate Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.756 | 0.489 | 2m | $6.1m | $3.3m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
FULC.NASDAQ | Fulcrum Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.859 | 0.536 | 1.1m | $4.7m | $5.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
GLPG.NASDAQ | Galapagos NV ADR | USA | Healthcare | Biotechnology | 2024-09-30 | 0.273 | 0.393 | 180k | $8.1m | $4.8m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
GLUE.NASDAQ | Monte Rosa Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.514 | 0.374 | 930k | $2.3m | $6.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
IKNA.NASDAQ | Ikena Oncology Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.669 | 0.067 | 322.6k | $897.6k | $493.6k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
IMNM.NASDAQ | Immunome Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.606 | 0.902 | 1m | $3.4m | $11m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
IMTX.NASDAQ | Immatics NV | USA | Healthcare | Biotechnology | 2024-09-30 | 3.085 | 3.245 | 3.7m | $12.2m | $26.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
INBX.NASDAQ | Inhibrx Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 3.228 | 6.159 | 1.5m | $17.6m | $22.1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
ITOS.NASDAQ | Iteos Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.806 | 0.794 | 1m | $15m | $7.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
JANX.NASDAQ | Janux Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.924 | 1.671 | 485k | $5.8m | $27.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
JAZZ.NASDAQ | Jazz Pharmaceuticals PLC | USA | Healthcare | Biotechnology | 2024-09-30 | 1.489 | 7.604 | 900k | $59.4m | $111.3m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 6/10 | 60.0% | | Total | 6/10 | 60.0% | |
---|
| |
KALV.NASDAQ | Kalvista Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-07-31 | 8.128 | 3.513 | 4m | $14m | $35m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
LQDA.NASDAQ | Liquidia Technologies Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.772 | 1.138 | 1.5m | $1.9m | $17.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
LYRA.NASDAQ | Lyra Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.312 | 0.412 | 800k | $252k | $137.6k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
MGNX.NASDAQ | MacroGenics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.322 | 0.207 | 830k | $1.5m | $2.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 8/10 | 80.0% | | Total | 8/10 | 80.0% | |
---|
| |
NARI.NASDAQ | Inari Medical Inc | USA | Healthcare | Medical Devices | 2024-09-30 | 2.648 | 4.848 | 1.5m | $11.5m | $83.1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
PASG.NASDAQ | Passage Bio Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 9.876 | 0.324 | 6.1m | $7.1m | $3.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
PCRX.NASDAQ | Pacira BioSciences, Inc. | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 2.581 | 4.289 | 1.2m | $19.4m | $23.3m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
PRAX.NASDAQ | Praxis Precision Medicines Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.478 | 1.357 | 440k | $8.9m | $33.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
PRME.NASDAQ | Prime Medicine, Inc. Common Stock | USA | Healthcare | Biotechnology | 2024-09-30 | 0.816 | 0.314 | 1m | $1.5m | $2.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
PYXS.NASDAQ | Pyxis Oncology Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.757 | 0.084 | 440k | $1.1m | $704k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
QURE.NASDAQ | Uniqure NV | USA | Healthcare | Biotechnology | 2024-09-30 | 9.745 | 1.776 | 4.7m | $5.4m | $82.4m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
RARE.NASDAQ | Ultragenyx | USA | Healthcare | Biotechnology | 2024-09-30 | 1.949 | 5.516 | 1.8m | $6.6m | $78.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
RLMD.NASDAQ | Relmada Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.624 | 0.12 | 490k | $773.2k | $176.8k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
RPHM.NASDAQ | RPHM.NASDAQ | - | - | - | - | 1.63 | 0.061 | 545k | - | - | | |
SLDB.NASDAQ | Solid Biosciences LLC | USA | Healthcare | Biotechnology | 2024-09-30 | 7.008 | 1.48 | 2.8m | $11.2m | $11.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
SLNO.NASDAQ | Soleno Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.67 | 2.757 | 720k | $4.4m | $32.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
SVRA.NASDAQ | Savara Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 4.714 | 2.601 | 8m | $7.6m | $25.8m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
TENX.NASDAQ | Tenax Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.445 | 0.022 | 83.3k | $382.8k | $470.8k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
VRDN.NASDAQ | Viridian Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.567 | 2.307 | 1m | $8.9m | $19.1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
VTYX.NASDAQ | Ventyx Biosciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.44 | 0.285 | 1.7m | $6.7m | $3.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
VYGR.NASDAQ | Voyager Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.897 | 0.217 | 490k | $2.7m | $2.8m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |